CIP2A and neoplasm: Huang et al., identified and evaluated CIP2A (both mRNA or protein) as a novel reliable and sensitive biomarker for diagnostics (early detection) in cervical cancer [93]).Their studies indicated that CIP2A (mRNA/protein) was specifically expressed (1) in cervical cancer tissues (different cancer stages), but not in non-cancer or adjacent non-tumor cervical tissue and (2) in cervical cell lines, but not in normal epithelial cell lines.